Exclusive

Publication

Byline

Location

US Patent Issued to JANSSEN SCIENCES IRELAND UNLtd. on May 12 for "Heterocyclic immunomodulators as PDL1 checkpoint inhibitor" (Belgian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,022, issued on May 12, was assigned to JANSSEN SCIENCES IRELAND UNLtd. COMPANY (County Cork, Ireland). "Heterocyclic immunomodulators as PDL... Read More


US Patent Issued to NodThera on May 12 for "Sulfonylurea derivatives and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,023, issued on May 12, was assigned to NodThera Ltd. (Little Chesterford, Great Britain). "Sulfonylurea derivatives and uses thereof" was in... Read More


US Patent Issued to Reservoir Neuroscience on May 12 for "EP2 antagonist compounds" (California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,024, issued on May 12, was assigned to Reservoir Neuroscience Inc. (San Francisco). "EP2 antagonist compounds" was invented by Matthew Alexa... Read More


US Patent Issued to DISARM THERAPEUTICS on May 12 for "Inhibitors of SARM1" (British, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,025, issued on May 12, was assigned to DISARM THERAPEUTICS INC. (Cambridge, Mass.). "Inhibitors of SARM1" was invented by Robert Owen Hughes... Read More


US Patent Issued to DISARM THERAPEUTICS on May 12 for "Inhibitors of SARM1" (British, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,026, issued on May 12, was assigned to DISARM THERAPEUTICS INC. (Cambridge, Mass.). "Inhibitors of SARM1" was invented by Robert Owen Hughes... Read More


US Patent Issued to ELLIPSES PHARMA, INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) on May 12 for "Salts and polymorphic forms of 6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-bpyridine" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,027, issued on May 12, was assigned to ELLIPSES PHARMA LTD (London) and INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) (London). ... Read More


US Patent Issued to Vertex Pharmaceuticals on May 12 for "1H-pyrazolo[4,3-Gisoquinoline and 1H-pyrazolo[4,3-gquinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)" (Massachusetts, Connecticut, California, New Hampshire, North Carolina Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,028, issued on May 12, was assigned to Vertex Pharmaceuticals Inc. (Boston). "1H-pyrazolo[4,3-Gisoquinoline and 1H-pyrazolo[4,3-gquinoline d... Read More


US Patent Issued to Galderma Holding on May 12 for "JAK inhibitor compounds, method for synthesizing same and use thereof" (French, British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,029, issued on May 12, was assigned to Galderma Holding SA (Zug, Switzerland). "JAK inhibitor compounds, method for synthesizing same and us... Read More


US Patent Issued to Principia Biopharma on May 12 for "4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-cpyridin-2-one derivatives and salts thereof" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,030, issued on May 12, was assigned to Principia Biopharma Inc. (Morristown, N.J.). "4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-... Read More


US Patent Issued to Northwestern University on May 12 for "Inhibitors of ubiquitin specific peptidase 22 (USP22) and uses thereof for treating diseases and disorders" (Illinois Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,031, issued on May 12, was assigned to Northwestern University (Evanston, Ill.). "Inhibitors of ubiquitin specific peptidase 22 (USP22) and ... Read More